Evidence map›Paper›PMID 12124278›Full record

ArticleBiophysical journal2002

Nerve growth factor signals via preexisting TrkA receptor oligomers.

Paul S Mischel, Joy A Umbach, Sepehr Eskandari, Shane G Smith, Cameron B Gundersen, Guido A Zampighi

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Nerve growth factor: role in growth, differentiation and controlling cancer cell development.Journal of experimental & clinical cancer research : CR · 2016
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Paul S MischelDepartment of Pathology and Laboratory Medicine, UCLA School of Medicine, University of California, Los Angeles, California 90095-1732 USA. pmischel@mednet.ucla.edu
Joy A Umbach
Sepehr Eskandari
Shane G Smith
Cameron B Gundersen
Guido A Zampighi
University of California, Los Angeles · US

Funding

STRUCTURE/FUNCTION OF LENS COMMUNICATING CHANNELSR01EY004110 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZAMPIGHI, GUIDO A · 1986 to 2011
$3.8M
GENE EXPRESSION BASED CLASSIFICATION OF GLIAL TUMORSU01CA088127 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NELSON, STANLEY F. · 2000 to 2004
$3.1M
PRESYNAPTIC CALCIUM CHANNELS &CYSTEINE STRING PROTEINSR01NS031934 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI UMBACH, JOY A · 1993 to 2004
$1.7M
STRUCTURE AND FUNCTION OF CYSTEINE STRING PROTEINSR01MH059938 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GUNDERSEN, CAMERON B · 2000 to 2003
$822k
Trk receptor mediated apoptosis of medulloblastoma cellsK08NS043147 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MISCHEL, PAUL S · 2001 to 2005
$609k
NCI NIH HHS U01 CA88127NEI NIH HHS EY-04110NIMH NIH HHS MH-59938NINDS NIH HHS K08NS43147-01NINDS NIH HHS NS31934
6 · The paper itself

Abstract

Nerve growth factor (NGF) promotes neuronal survival and differentiation by activating TrkA receptors. Similar to other receptor tyrosine kinases, ligand-induced dimerization is thought to be required for TrkA receptor activation. To study this process, we expressed TrkA receptors in Xenopus laevis oocytes and analyzed their response to NGF by using a combination of functional, biochemical, and structural approaches. TrkA receptor protein was detected in the membrane fraction of oocytes injected with TrkA receptor cRNA, but not in uninjected or mock-injected oocytes. Application of NGF to TrkA receptor-expressing oocytes promoted tyrosine phosphorylation and activated an oscillating transmembrane inward current, indicating that the TrkA receptors were functional. Freeze-fracture electron microscopic analysis demonstrated novel transmembrane particles in the P-face (protoplasmic face) of oocytes injected with TrkA cRNA, but not in uninjected or mock injected oocytes. Incubating TrkA cRNA-injected oocytes with the transcriptional inhibitor actinomycin D did not prevent the appearance of these P-face particles or electrophysiological responses to NGF, demonstrating that they did not arise from de novo transcription of an endogenous Xenopus oocyte gene. The appearance of these particles in the plasma membrane correlated with responsiveness to NGF as detected by electrophysiological analysis and receptor phosphorylation, indicating that these novel P-face particles were TrkA receptors. The dimensions of these particles (8.6 x 10 nm) were too large to be accounted for by TrkA monomers, suggesting the formation of TrkA receptor oligomers. Application of NGF did not lead to a discernible change in the size or shape of these TrkA receptor particles during an active response. These results indicate that in Xenopus oocytes, NGF activates signaling via pre-formed TrkA receptor oligomers.

Indexed as

AnimalsCell DifferentiationCell MembraneCell SurvivalDactinomycinDimerizationElectrophysiologyFreeze FracturingImmunoblottingMicroscopy, ElectronNerve Growth FactorProtein BindingReceptor, trkARNA, ComplementarySignal TransductionXenopus laevisDactinomycinNerve Growth FactorReceptor, trkARNA, Complementary

Identifiers

PMID12124278
PMCPMC1302200
OpenAlexW2035788880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.